Stock listing

Biofrontera Ag

Selected listing: B8FK · XETR · EUR · DE

Biofrontera Ag (Xetra:B8FK), Health Technology. Latest release May 29, 2026: Biofrontera AG: BIOFRONTERA REPORTS RESULTS FOR THE FIRST QUARTER OF 2026.

B8FK:XETREURDEUpdated October 3, 2026

Ticker: Xetra:B8FK
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Xetra
Currency: EUR

About Biofrontera Ag

Biofrontera AG is a public company traded under the ticker B8FK on the German market. Biofrontera focuses on developing and commercializing dermatological products, particularly for the treatment of skin conditions.

Latest news from Biofrontera Ag

Biofrontera AG: BIOFRONTERA REPORTS RESULTS FOR THE FIRST QUARTER OF 2026

May 29, 2026

Biofrontera : Compensation report 2025 incl. audit opinion (Compensation report 2025 incl. audit opinion)

April 30, 2026

Biofrontera : Report of Supervisory Board 2025 (Report of Supervisory Board 2025)

April 30, 2026

Biofrontera AG: BIOFRONTERA REPORTS RESULTS FOR THE FINANCIAL YEAR 2025

April 17, 2026

Biofrontera AG: Financial Guidance for FY 2026

March 10, 2026

All Biofrontera Ag news →

Research Biofrontera Ag

Biofrontera Ag company profile

View the public company page for Biofrontera Ag on 6ix.

Biofrontera Ag news

Read company news and market updates connected to Biofrontera Ag.

Biofrontera Ag investor events

Find investor webinars, events, and replay context for Biofrontera Ag.